About
Scisparc Ltd (NASDAQ:SPRC) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 16 2026
SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy
Mar 13 2026
Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
Mar 12 2026
SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
Mar 10 2026
Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
Mar 10 2026
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails
Financials
Revenue
$1.31 M
Market Cap
$2 M
P/E Ratio
0.00
EPS
3156.52
Translate